https://en.wikipedia.org/wiki/James_P._Allison Honors In 2011 Allison won the Jacob Heskel Gabbay Award for Biotechnology and Medicine[19] and was awarded the American Association of Immunologists Lifetime Achievement Award.[20] In 2013 he shared the Novartis Prize for Clinical Immunology. In 2014 he shared the first Tang Prize in Biopharmaceutical Science with Tasuku Honjo,[2] won the 9th Annual Szent-Györgyi Prize for Progress in Cancer Research of the National Foundation for Cancer Research, received the $3 million Breakthrough Prize in Life Sciences, the Canada Gairdner International Award,[21] the Louisa Gross Horwitz Prize,[22] and the Harvey Prize [23] of the Technion Institute of Technology in Haifa. In 2015, he received the Lasker-DeBakey Clinical Medical Research Award.[3]
In 2017 he received the Wolf Prize in Medicine [24] and the Balzan Prize for Immunological Approaches in Cancer Therapy (this prize jointly with Robert D. Schreiber).[25] In 2018 he received the King Faisal International Prize in Medicine,[26] the Jessie Stevenson Kovalenko Medal and the Albany Medical Center Prize in Medicine and Biomedical Research.[27]
He, along with Tasuku Honjo, was jointly awarded the Nobel Prize in Physiology or Medicine in 2018 for their discovery of cancer therapy by inhibition of negative immune regulation.[28][29][30]
News 
Market Data 
Discover 
